Alex E. Roher
- Physiology top 0.05%
- Alzheimer's disease research and treatments 112
- Neurology top 0.05%
- Neuroinflammation and Neurodegeneration Mechanisms 16
- Biological Psychiatry top 0.5%
- Clinical Biochemistry top 0.1%
- Advanced Glycation End Products research 12
- Pharmacology top 0.2%
- Cholinesterase and Neurodegenerative Diseases 28
-
- Dementia and Cognitive Impairment Research 26
-
- Prion Diseases and Protein Misfolding 24
- Protein Structure and Dynamics 10
-
- Computational Drug Discovery Methods 14
- Co-authors
- Yu‐Min KuoThomas G. BeachTyler A. KokjohnMark R. EmmerlingMelvyn J. BallLucia I. SueRobert J. CotterAmina S. Woods
- Journals
- Journal of Biological Chemistry (10 papers)Journal of Alzheimer s Disease (7 papers)Biochemistry (6 papers)
- Partner nations
- United StatesArgentinaUnited Kingdom
In The Last Decade
Alex E. Roher
136 papers receiving 16.3k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Physiology 11.9k
- Neurology 3.7k
- Biological Psychiatry 687
- Clinical Biochemistry 1.5k
- Pharmacology 2.3k
Countries citing papers authored by Alex E. Roher
This map shows the geographic impact of Alex E. Roher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex E. Roher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex E. Roher more than expected).
Fields of papers citing papers by Alex E. Roher
This network shows the impact of papers produced by Alex E. Roher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex E. Roher. The network helps show where Alex E. Roher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alex E. Roher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 80 | |
| 2 | Chemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumab. | 2016 | 12 |
| 3 | 2012 | 29 | |
| 4 | 2011 | 46 | |
| 5 | 2011 | 54 | |
| 6 | 2006 | 162 | |
| 7 | 2006 | 47 | |
| 8 | 2006 | 162 | |
| 9 | 2005 | 81 | |
| 10 | 2003 | 20 | |
| 11 | 2002 | 2 | |
| 12 | 2002 | 71 | |
| 13 | 2001 | 216 | |
| 14 | 2000 | 50 | |
| 15 | 2000 | 67 | |
| 16 | 1998 | 90 | |
| 17 | Cerebral Amyloid Angiopathybreakdown → | 1998 | 529 |
| 18 | 1994 | 116 | |
| 19 | 1991 | 93 | |
| 20 | 1988 | 27 |
About Alex E. Roher
Alex E. Roher is a scholar working on Physiology, Neurology and Clinical Biochemistry, having authored 136 papers that have together received 16.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (112 papers), Cholinesterase and Neurodegenerative Diseases (28 papers), Dementia and Cognitive Impairment Research (26 papers), Prion Diseases and Protein Misfolding (24 papers), Neuroinflammation and Neurodegeneration Mechanisms (16 papers), Computational Drug Discovery Methods (14 papers), Advanced Glycation End Products research (12 papers) and Protein Structure and Dynamics (10 papers). The work is most often cited by research in Physiology (11.9k citations), Neurology (3.7k citations) and Biological Psychiatry (687 citations). Alex E. Roher has collaborated with scholars based in United States, Argentina and United Kingdom. Frequent co-authors include Yu‐Min Kuo, Thomas G. Beach, Tyler A. Kokjohn, Mark R. Emmerling, Melvyn J. Ball, Lucia I. Sue, Robert J. Cotter, Amina S. Woods, Shi Du Yan and David M. Stern. Their work appears in journals such as Journal of Biological Chemistry, Journal of Alzheimer s Disease, Biochemistry, Neurological Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.